XML 62 R18.htm IDEA: XBRL DOCUMENT
v3.23.1

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Accounting Changes and Error Corrections [Abstract] |
Schedule of Restatement of Previously Issued Financial Statements | Balance Sheets: The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported balance sheet as of June 30, 2022:
|  | As of June 30, 2022 |
|  | As Previously Reported |  |  | Restatement Adjustment |  |  | As Restated |
Total Assets |  | $ | 276,393,463 |  |  | $ | — |  |  | $ | 276,393,463 |
Total current liabilities |  |  | 412,495 |  |  |  | — |  |  |  | 412,495 |
Deferred underwriting commissions |  |  | 9,625,000 |  |  |  | (3,609,375 | ) |  |  | 6,015,625 |
Total liabilities |  |  | 10,037,495 |  |  |  | (3,609,375 | ) |  |  | 6,428,120 |
Class A ordinary shares subject to possible redemption |  |  | 275,043,954 |  |  |  | — |  |  |  | 275,043,954 |
Preferred shares |  |  | — |  |  |  | — |  |  |  | — |
Class A ordinary shares |  |  | 91 |  |  |  | — |  |  |  | 91 |
Class B ordinary shares |  |  | 688 |  |  |  | — |  |  |  | 688 |
Additional paid-in capital |  |  | — |  |  |  | — |  |  |  | — |
Accumulated deficit |  |  | (8,688,765 | ) |  |  | 3,609,375 |  |  |  | (5,079,390 | )
Total shareholders’ deficit |  |  | (8,687,986 | ) |  |  | 3,609,375 |  |  |  | (5,078,611 | )
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |  | $ | 276,393,463 |  |  | $ | — |  |  | $ | 276,393,463 |
The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported balance sheet as of September 30, 2022:
|  | As of September 30, 2022 |
|  | As Previously Reported |  |  | Restatement Adjustment |  |  | As Restated |
Total Assets |  | $ | 276,978,583 |  |  | $ | — |  |  | $ | 276,978,583 |
Total current liabilities |  |  | 467,636 |  |  |  | — |  |  |  | 467,636 |
Deferred underwriting commissions |  |  | 9,625,000 |  |  |  | (3,609,375 | ) |  |  | 6,015,625 |
Total liabilities |  |  | 10,092,636 |  |  |  | (3,609,375 | ) |  |  | 6,483,261 |
Class A ordinary shares subject to possible redemption |  |  | 275,905,944 |  |  |  | — |  |  |  | 275,905,944 |
Preferred shares |  |  | — |  |  |  | — |  |  |  | — |
Class A ordinary shares |  |  | 91 |  |  |  | — |  |  |  | 91 |
Class B ordinary shares |  |  | 688 |  |  |  | — |  |  |  | 688 |
Additional paid-in capital |  |  | — |  |  |  | — |  |  |  | — |
Accumulated deficit |  |  | (9,020,776 | ) |  |  | 3,609,375 |  |  |  | (5,411,401 | )
Total shareholders’ deficit |  |  | (9,019,997 | ) |  |  | 3,609,375 |  |  |  | (5,410,622 | )
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |  | $ | 276,978,583 |  |  | $ | — |  |  | $ | 276,978,583 |
Statement of Changes in Stockholders’ Deficit: The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported accumulated deficit in the statement of changes in stockholders’ deficit for the six months ended June 30, 2022:
|  | For the Six Months Ended June 30, 2022 |
|  | As Previously Reported |  |  | Restatement Adjustment |  |  | As Restated |
Balance—December 31, 2021 |  | $ | (8,053,173 | ) |  | $ | — |  |  | $ | (8,053,173 | )
Adjustment for accretion of Class A ordinary shares subject to possible redemption amount |  |  | (43,954 | ) |  |  | 3,609,375 |  |  |  | 3,565,421 |
Net loss |  |  | (591,638 | ) |  |  | — |  |  |  | (591,638 | )
Balance—June 30, 2022 |  | $ | (8,688,765 | ) |  | $ | 3,609,375 |  |  | $ | (5,079,390 | )
The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported accumulated deficit in the statement of changes in stockholders’ deficit for the nine months ended September 30, 2022:
|  | For the Nine Months Ended September 30, 2022 |
|  | As Previously Reported |  |  | Restatement Adjustment |  |  | As Restated |
Balance—December 31, 2021 |  | $ | (8,053,173 | ) |  | $ | — |  |  | $ | (8,053,173 | )
Adjustment for accretion of Class A ordinary shares subject to possible redemption amount |  |  | (905,944 | ) |  |  | 3,609,375 |  |  |  | 2,703,431 |
Net loss |  |  | (61,659 | ) |  |  | — |  |  |  | (61,659 | )
Balance—September 30, 2022 |  | $ | (9,020,776 | ) |  | $ | 3,609,375 |  |  | $ | (5,411,401 | )
Statement of Cash Flows: The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the six months ended June 30, 2022:
|  | For the Six Months Ended June 30, 2022 |
|  | As Previously Reported |  |  | Restatement Adjustment |  |  | As Restated |
Supplemental disclosure of noncash financing activities: |  |  |  |  |  |  |  |  |  |  |  |
Extinguishment of deferred underwriting commissions allocated to Public Shares |  | $ | — |  |  | $ | 3,609,375 |  |  | $ | 3,609,375 |
The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the nine months ended September 30, 2022:
|  | For the Nine Months Ended September 30, 2022 |
|  | As Previously Reported |  |  | Restatement Adjustment |  |  | As Restated |
Supplemental disclosure of noncash financing activities: |  |  |  |  |  |  |  |  |  |  |  |
Extinguishment of deferred underwriting commissions allocated to Public Shares |  | $ | — |  |  | $ | 3,609,375 |  |  | $ | 3,609,375 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingChangesAndErrorCorrectionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 13 -URI https://asc.fasb.org/extlink&oid=126900757&loc=d3e765-108305 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 12 -URI https://asc.fasb.org/extlink&oid=126900757&loc=d3e725-108305 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794 + Details
Name: | us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration